Massachusetts General Hospital
Background data
Program Type : Adult ProgramFACT Approved: Yes
Year CAR T-cell Therapy Program Opened:
Location Info
Massachusetts General HospitalCellular Immunotherapy Program
55 Fruit St
Boston, , 02114
Boston, , 02114
Website : https://www.massgeneral.org/cancer-center/treatments-and-services/bone-marrow-transplant
CAR T-cell therapies performed
Numbers displayed are the most recent data provided by this center.Year | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Number performed | 36 | 43 | 59 | 115 | 120 |
Program Director
Name | Phone |
---|---|
Marcela Maus, MD, PhD |
Medical Director
Name | Phone |
---|---|
Yi-Bin Chen, MD | (617) 726-5765 |
Physician
Name | Phone |
---|---|
Jeremy Abramson, MD | (617) 724-4000 |
Andrew Branagan, MD | (617) 724-4000 |
Diane Cirstea, MD | (617) 643-0097 |
Zachariah DeFilipp, MD | (617) 724-3456 |
Areej El-Jawahri, MD | (617) 724-3456 |
Matthew Frigault, MD | (617) 724-3456 |
Julie Erika Haydu, MD, PhD | (617) 724-4000 |
Patrick Connor Johnson, MD | (617) 724-4000 |
Mark Leick, MD | (617) 724-3456 |
Steven McAfee, MD | (617) 724-3456 |
Rupa Narayan, MD | (617) 726-6533 |
Noopur Raje, MD | (617) 724-1969 |
Jacob Soumerai, MD | (617) 724-4000 |
Thomas Spitzer, MD | (617) 724-3456 |
Diseases treated by CAR T-cell therapy
- Leukemia, acute lymphoblastic
- Lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
CAR T-Cell products
- Abecma (idecabtagene vicleucil, ide-cel)
- Breyanzi (lisocabtagene maraleucel, liso-cel)
- Carvykti (ciltacabtagene autoleucel, cita-cel)
- Kymriah (tisagenlecleucel, tisa-cel)
- Tecartus (brexucabtagene autoleucel, brexu-cel)
- Yescarta (axicabtagene ciloleucel, axi-cel)